Development asset linked to Bavarian Nordic in public FDA and regional records.
pharma Β· Chikungunya Virus
Bavarian Nordic
Bavarian Nordic A/S
Bavarian Nordic drug portfolio β 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Copenhagen, DK HQ
1994 Founded
1,730 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Copenhagen, DK
- Founded
- 1994
- Employees
- 1,730
- Programs
- 1
- Drugs
- 1
- Patents
- 25
Bavarian Nordic pipeline
Portfolio lens on 1 drugs and development assets β regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Bavarian Nordic drug portfolio β 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.